Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.

@article{Goto2007SelectiveIE,
  title={Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.},
  author={Kouichiro Goto and Yuto Kamiya and Takeshi Imamura and Kohei Miyazono and Keiji Miyazawa},
  journal={The Journal of biological chemistry},
  year={2007},
  volume={282 28},
  pages={20603-11}
}
The inhibitory Smads, Smad6 and Smad7, play pivotal roles in negative regulation of transforming growth factor-beta (TGF-beta) family signaling as feedback molecules as well as mediators of cross-talk with other signaling pathways. Whereas Smad7 acts as a ubiquitous inhibitor of Smad signaling, Smad6 has been shown to effectively inhibit bone morphogenetic protein (BMP) signaling but only weakly TGF-beta/activin signaling. In the present study, we have found that Smad6 inhibits signaling from… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 45 extracted citations

Signaling Receptors for TGF-β Family Members.

Cold Spring Harbor perspectives in biology • 2016
View 7 Excerpts
Highly Influenced

Regulation of Gastric Metaplasia, Dysplasia, and Neoplasia by Bone Morphogenetic Protein Signaling

Cellular and molecular gastroenterology and hepatology • 2017
View 2 Excerpts

Similar Papers

Loading similar papers…